[April 17, 2012]

Thermo Fisher Scientific Showcases Product and Service Innovations in Europe that Streamline Laboratory Processes while Improving Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today introduced innovative new products and services to the European scientific community at Analytica - the premier international trade fair for laboratory technology, analysis and biotechnology - that push the boundaries of analysis while helping customers to improve productivity in today's increasingly competitive environment.

Visitors to the company's Thermo Scientific booth 101/202 and Fisher Scientific booth 111/210 will learn about its latest offerings for the general laboratory and specialized life science applications represented by these two premier brands, as well as its new Unity™ Lab Services offering for comprehensive laboratory management services. Analytica is being held at the New Munich Trade Fair Centre from April 17-20.

"While economic pressures are forcing our customers to be more productive, the need to address complex healthcare, environmental and industrial challenges is equally pressing," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "By leveraging our scale and depth of capabilities, Thermo Fisher is uniquely positioned to help them achieve both objectives. Our commitment to innovation is demonstrated by the range of new offerings designed to significantly improve our customers' laboratory operations while raising the standards of their analytical results."

Improving Productivity and Performance in Research and Applied Markets

Thermo Fisher offers chromatography solutions for customers working in life sciences, environmental, food safety and industrial markets. Making its debut for the European community is the first commercially available integrated capillary high-pressure ion chromatography (HPIC™) system, the Thermo Scientific Dionex ICS-4000. The ICS-4000 is ideal for demanding 24/7 routine analyses, offering speed without compromising chromatographic resolution. For applications requiring more precise measurements and higher throughput, the Thermo Scientific Dionex ICS-5000 is a flexible and modular system that offers high-pressure capabilities to bring near-UHPLC performance to IC.

The Trace™ 1300 Series gas chromatography (GC) system is designed specifically to enable laboratories to be more productive without compromising performance. The Trace 1300 platform features unique patented instant-connect injectors and detectors that introduce a new level of flexibility for reduced costs in QA/QC and general laboratories. Each of the chromatography instruments featured runs on the gold standard Thermo Scientific Dionex Chromeleon™ Chromatography Data System (CDS).

Making its Analytica debut is the Thermo Scientific Q Exactive™ high-performance benchtop Orbitrap^® mass spectrometer, the first commercially available instrument to bring together high-performance quadrupole MS capability with the ultrahigh-resolution accurate mass Orbitrap platform. The ultimate in performance and productivity for routine analysis, the Q-Exactive mass spectrometer enables the operator to conduct three experiments at once - identification, quantitation and confirmation - in a system that is fully compatible with UHPLC separations.

The new Thermo Scientific iCAP™ Q instrument brings innovation to inductively coupled plasma (ICP). It is an ICP-MS system with unique ion-focusing technology that improves signal-to-noise performance and increases laboratory throughput by up to 50 percent when compared to existing technology.

New to the European market is the Thermo Scientific Gallery™ Plus, a discrete photometric analyzer that allows food, beverage and water analysis laboratories to simplify testing and improve productivity.

Thermo Fisher has expanded its comprehensive offering for laboratory water purification to include the new Thermo Scientific GenPure, Thermo Scientific Smart2Pure and Thermo Scientific LabTower systems. Innovative features include advanced electrodeionization (EDI) capabilities, a flexible remote dispenser, and complementary consumables and accessories.

Specialized Life Science Applications Demand Unique Solutions

Long considered a leader in meeting the growing demand for bioscience reagents and consumables, Thermo Fisher introduced two new instruments for life science researchers that further address the need for simpler workflows. The new Thermo Scientific MYECL™ Imager enables the analysis of chemiluminescent western blots, stained protein gels and nucleic acid gels using an automated process that is a highly effective substitute for the laboratory darkroom and traditional X-ray film.

The Thermo Scientific PikoReal™ Real-Time PCR System also makes its Analytica debut as part of a comprehensive molecular biology workflow comprising instruments, reagents and consumables. Available in 24- and 96-well instrument formats, the PikoReal offers outstanding PCR (News - Alert) performance in a small bench-top footprint ideal for personalized use.

Thermo Fisher is also highlighting its capabilities for biobanking, including sample database management software, new ultralow-temperature freezers and laboratory consumables designed for increased laboratory efficiency and greater sample integrity.

For managing critical information, the Thermo Scientific VisionTracker database software enables more accurate and efficient data management, tracking and retrieval of biological, chemical and other samples. It is simple to install and configure with pre-loaded data for Thermo Scientific tubes, boxes, freezers and barcode readers, eliminating the need for manual data logging and reducing the risk of errors for improved efficiency.

The Thermo Scientific HERAfreeze™ HFU T Series freezers provide outstanding sample protection while maintaining improved standards for energy efficiency and capacity. Available in five new capacities, Thermo Scientific freezers provide a number of options to suit any storage or laboratory space requirements. In addition, Thermo Fisher provides a selection of consumables specially designed to meet stringent standards for sample handling. New Thermo Scientific Matrix Amber 2D bar-coded tubes expand Thermo Fisher's extensive sample storage product portfolio to offer protection of light-sensitive samples, while the new Thermo Scientific Universal Latch Rack offers easier ergonomic tube storage.

Finally, for cell culture applications, Thermo Fisher addresses critical factors such as lab space, efficiency and sample protection with stackable Thermo Scientific Heratherm™ microbiological incubators, the energy-saving, bench-top Thermo Scientific Heratherm™ heating and drying ovens as well as new Thermo Scientific Nalgene™ Rapid-Flow Filters and Thermo Scientific Nunc™ Edge 96-well Plates.

For access to all Thermo Fisher news and product photos related to Analytica 2012, please visit our online media room at www.thermofisher.com/news.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2011, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission and available in the "Investors" section of our website under the heading "SEC (News - Alert) Filings." Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general worldwide economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; the effect of healthcare reform legislation; use and protection of intellectual property; the effect of changes in governmental regulations; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to the acquisitions of Dionex and Phadia may not materialize as expected. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

[ Back To TMCnet.com's Homepage ]